Cargando…
Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder
Attention deficit hyperactivity disorder (ADHD) is the most commonly diagnosed neurobehavioural disorder in childhood, affecting over 5% of children worldwide. As well as the core symptoms of inattention, hyperactivity and impulsivity, patients often exhibit learning difficulties and impairment in s...
Autor principal: | Takon, Inyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204268/ https://www.ncbi.nlm.nih.gov/pubmed/21962224 http://dx.doi.org/10.1186/1744-859X-10-25 |
Ejemplares similares
-
Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015) -
Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
por: Gomez-Sanchez, Clara I., et al.
Publicado: (2017) -
Continuity in Methylphenidate Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
por: Olfson, Mark, et al.
Publicado: (2007) -
An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified-release methylphenidate
por: Hautmann, Christopher, et al.
Publicado: (2013) -
The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008)